AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesInformation ScienceHealth Care
ViremiaViral LoadRNA, ViralAntibodies, ViralThorium DioxideRhabdoviridaeHIV InfectionsHIV-1CarpsAlphavirus InfectionsHepatitis CAntiretroviral Therapy, Highly ActiveDNA, ViralRhabdoviridae InfectionsSimian immunodeficiency virusSimian Acquired Immunodeficiency SyndromeHepatitis C AntibodiesCD4 Lymphocyte CountCytomegalovirus InfectionsAlphavirusAnti-HIV AgentsHepatitis, Viral, AnimalHepacivirusFish DiseasesDengueViral VaccinesVirus ReplicationAlanine TransaminaseHepadnaviridae InfectionsParvoviridae InfectionsFoot-and-Mouth DiseaseHepatitis AntibodiesAntiviral AgentsArterivirus InfectionsNeutralization TestsPolymerase Chain ReactionCD4-Positive T-LymphocytesCytomegalovirusMacaca mulattaBloodAntigens, ViralHepatitis C, ChronicTime FactorsCD8-Positive T-LymphocytesEnzyme-Linked Immunosorbent AssayMolecular Sequence DataBK VirusGenotypeHepatitis BDisease Models, AnimalReverse Transcriptase Polymerase Chain ReactionImmunoglobulin GSwinePolyomavirus InfectionsSequence Analysis, DNASAIDS VaccinesDengue VirusFlaviviridae InfectionsGB virus CLymphocyte ActivationProspective StudiesTreatment OutcomeLiverHIVVirus SheddingDNA Virus InfectionsPorcine Reproductive and Respiratory SyndromeAntibodies, NeutralizingWest Nile FeverWest Nile virusFollow-Up Studies
VirologicDetectionPeople
Virologic1
  • Evaluation of virologic failure should include an assessment of ART adherence, drug-drug and drug-food interactions, drug tolerability, HIV-RNA level and CD4 T lymphocyte (CD4) cell count trends over time, ART history, and prior and current drug-resistance test results. (hiv.gov)
Detection2
  • Antiretroviral (ARV) regimens that are currently recommended for initial therapy in patients with HIV have a high likelihood of achieving and maintaining plasma HIV-RNA levels that are below the lower limits of detection (LLOD) of currently used assays (see What to Start ). (hiv.gov)
  • This study compared HCV RNA with HCVcAg for the detection and quantification of viraemia among a sample of Egyptians. (who.int)
People2
  • After achieving virologic suppression of less than 50 copies/ml, most (more than half) of people living with HIV on ART maintain a residual HIV viremia at very low levels (1-10 copies/ml) (2, 4, 5). (ohtn.on.ca)
  • This review summarizes various definitions of low-level viremia and related terms, as well as the current evidence on incidence, risk factors, and clinical outcomes of low-level viremia in people living with HIV and receiving ART. (ohtn.on.ca)